These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10688965)

  • 1. Role of third intracellular loop of galanin receptor type 1 in signal transduction.
    Rezaei K; Saar K; Soomets U; Valkna A; Näsman J; Zorko M; Akerman K; Schroeder T; Bartfai T; Langel U
    Neuropeptides; 2000 Feb; 34(1):25-31. PubMed ID: 10688965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction.
    Heydorn A; Ward RJ; Jorgensen R; Rosenkilde MM; Frimurer TM; Milligan G; Kostenis E
    Mol Pharmacol; 2004 Aug; 66(2):250-9. PubMed ID: 15266015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and biochemical characterization of a recombinant human galanin GALR1 receptor: agonist character of chimeric galanin peptides.
    Fitzgerald LW; Patterson JP; Conklin DS; Horlick R; Largent BL
    J Pharmacol Exp Ther; 1998 Nov; 287(2):448-56. PubMed ID: 9808667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineation of the peptide binding site of the human galanin receptor.
    Kask K; Berthold M; Kahl U; Nordvall G; Bartfai T
    EMBO J; 1996 Jan; 15(2):236-44. PubMed ID: 8617199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR structure of a human homologous methuselah gene receptor peptide.
    Kikkou T; Matsumoto O; Ohkubo T; Kobayashi Y; Tsujimoto G
    Biochem Biophys Res Commun; 2007 Jan; 352(1):17-20. PubMed ID: 17109822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
    Dautzenberg FM; Wille S
    Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for hydrophobic interaction between galanin and the GalR1 galanin receptor and GalR1-mediated ligand internalization: fluorescent probing with a fluorescein-galanin.
    Wang S; Clemmons A; Strader C; Bayne M
    Biochemistry; 1998 Jun; 37(26):9528-35. PubMed ID: 9649336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction.
    Brighton PJ; Szekeres PG; Wise A; Willars GB
    Mol Pharmacol; 2004 Dec; 66(6):1544-56. PubMed ID: 15331768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3',5'-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice.
    Badie-Mahdavi H; Lu X; Behrens MM; Bartfai T
    Neuroscience; 2005; 133(2):591-604. PubMed ID: 15885916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain.
    Berger H; Heinrich N; Wietfeld D; Bienert M; Beyermann M
    Br J Pharmacol; 2006 Dec; 149(7):942-7. PubMed ID: 17057757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional role of a C-terminal Gbetagamma-binding domain of Ca(v)2.2 channels.
    Li B; Zhong H; Scheuer T; Catterall WA
    Mol Pharmacol; 2004 Sep; 66(3):761-9. PubMed ID: 15322269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site of action of the general anesthetic propofol in muscarinic M1 receptor-mediated signal transduction.
    Murasaki O; Kaibara M; Nagase Y; Mitarai S; Doi Y; Sumikawa K; Taniyama K
    J Pharmacol Exp Ther; 2003 Dec; 307(3):995-1000. PubMed ID: 14534362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenesis and ligand modification studies on galanin binding to its GTP-binding-protein-coupled receptor GalR1.
    Berthold M; Kahl U; Juréus A; Kask K; Nordvall G; Langel U; Bartfai T
    Eur J Biochem; 1997 Oct; 249(2):601-6. PubMed ID: 9370372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple interaction sites of galnon trigger its biological effects.
    Florén A; Sollenberg U; Lundström L; Zorko M; Stojan J; Budihna M; Wheatley M; Martin NP; Kilk K; Mazarati A; Bartfai T; Lindgren M; Langel U
    Neuropeptides; 2005 Dec; 39(6):547-58. PubMed ID: 16297447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S111N mutation in the helical domain of human Gs(alpha) reduces its GDP/GTP exchange rate.
    Brito M; Guzmán L; Romo X; Soto X; Hinrichs MV; Olate J
    J Cell Biochem; 2002; 85(3):615-20. PubMed ID: 11968001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein-coupled galanin receptor distribution in the rat central nervous system.
    Barreda-Gómez G; Giralt MT; Rodríguez-Puertas R
    Neuropeptides; 2005 Jun; 39(3):153-6. PubMed ID: 15944004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity.
    Lu X; Mazarati A; Sanna P; Shinmei S; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):147-52. PubMed ID: 15944003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-protein betagamma-subunits contribute to the coupling specificity of the beta2-adrenergic receptor to G(s).
    Kühn B; Christel C; Wieland T; Schultz G; Gudermann T
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):231-41. PubMed ID: 11882919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the C terminus in neuropeptide Y Y1 receptor desensitization and internalization.
    Holliday ND; Lam CW; Tough IR; Cox HM
    Mol Pharmacol; 2005 Mar; 67(3):655-64. PubMed ID: 15576634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo.
    Pooga M; Soomets U; Hällbrink M; Valkna A; Saar K; Rezaei K; Kahl U; Hao JX; Xu XJ; Wiesenfeld-Hallin Z; Hökfelt T; Bartfai T; Langel U
    Nat Biotechnol; 1998 Sep; 16(9):857-61. PubMed ID: 9743120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.